ABBOTT INDIA
Back to Cashflow Statement
|
ABBOTT INDIA Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-118 Cr | ₹269 Cr | ₹52 Cr | ₹107 Cr | ₹-86 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ABBOTT INDIA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-118 Cr |
| Mar2025 | ₹269 Cr |
| Mar2024 | ₹52 Cr |
| Mar2023 | ₹107 Cr |
| Mar2022 | ₹-86 Cr |
How is Net Cash Inflow / Outflow of ABBOTT INDIA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-118 Cr | Negative | |
| Mar2025 | ₹269 Cr | 416.32 | |
| Mar2024 | ₹52 Cr | -51.32 | |
| Mar2023 | ₹107 Cr | Positive | |
| Mar2022 | ₹-86 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹59,076.6 Cr | -0.2% | 7.8% | -17.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -0.2% |
7.8% |
-17.7% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses